-
-
-
-
-
-
-
Dianthus Therapeutics Highlights Recent Business Achievements, Including GO Decision for Phase 3 CAPTIVATE CIDP Trial, and Reports Q4 and FY 2025 Financial Results
-
-
-
-
-
-
-
Dianthus Therapeutics (DNTH) Misses Q4 EPS by 81c
-
-
-
-
-
-
-
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results
-
-
1,198,644 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

